Brief Summary
Type:
Leukemias
Study Type:
Treatment
Phase:
I
ClinicalTrials.gov Identifier:
NCT03328104
Study #:
CMH - AflacLL1602
Start Date:
Jan 31, 2019
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT03328104
View Complete Trial Details & Eligibility at ClinicalTrials.gov
